Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998173885> ?p ?o ?g. }
- W2998173885 endingPage "67" @default.
- W2998173885 startingPage "67" @default.
- W2998173885 abstract "PD-1 pathway blockade has been shown to promote proatherogenic T-cell responses and destabilization of atherosclerotic plaques. Moreover, preclinical evidence suggests a potential synergy of antiplatelet drugs with immune checkpoint inhibitors (ICIs). We conducted an analysis within a prospective observational protocol (APOLLO study) to investigate the rates, predictors, and prognostic significance of thromboembolic events (TE) and thromboprophylaxis in patients with advanced NSCLC treated with ICIs. Among 217 patients treated between April 2014 and September 2018, 13.8% developed TE events. Current smoking status (HR 3.61 (95% CI 1.52–8.60), p = 0.004) and high (>50%) PD-L1 (HR 2.55 (95% CI 1.05–6.19), p = 0.038) resulted in being independent TE predictors. An increased risk of death following a diagnosis of TE (HR 2.93; 95% CI 1.59–5.42; p = 0.0006) was observed. Patients receiving antiplatelet treatment experienced longer progression-free survival (PFS) (6.4 vs. 3.4 months, HR 0.67 (95% CI 0.48–0.92), p = 0.015) and a trend toward better OS (11.2 vs. 9.6 months, HR 0.78 (95% CI 0.55–1.09), p = 0.14), which were not confirmed in a multivariate model. No impact of anticoagulant treatment on patients’ outcomes was observed. NSCLC patients treated with ICIs bear a consistent risk for thrombotic complications, with a detrimental effect on survival. The impact of antiplatelet drugs on ICIs efficacy deserves further investigation in prospective trials." @default.
- W2998173885 created "2020-01-10" @default.
- W2998173885 creator A5004176474 @default.
- W2998173885 creator A5005810267 @default.
- W2998173885 creator A5008445367 @default.
- W2998173885 creator A5009935310 @default.
- W2998173885 creator A5011289747 @default.
- W2998173885 creator A5018257698 @default.
- W2998173885 creator A5032833091 @default.
- W2998173885 creator A5056305832 @default.
- W2998173885 creator A5066152196 @default.
- W2998173885 creator A5071355244 @default.
- W2998173885 creator A5072550519 @default.
- W2998173885 creator A5085306324 @default.
- W2998173885 creator A5089982076 @default.
- W2998173885 creator A5091509029 @default.
- W2998173885 date "2019-12-25" @default.
- W2998173885 modified "2023-10-17" @default.
- W2998173885 title "Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients" @default.
- W2998173885 cites W1971949029 @default.
- W2998173885 cites W1995828607 @default.
- W2998173885 cites W1996600303 @default.
- W2998173885 cites W2023917164 @default.
- W2998173885 cites W2031799746 @default.
- W2998173885 cites W2063853621 @default.
- W2998173885 cites W2081716782 @default.
- W2998173885 cites W2087166268 @default.
- W2998173885 cites W2090928408 @default.
- W2998173885 cites W2104347254 @default.
- W2998173885 cites W2112878705 @default.
- W2998173885 cites W2119531959 @default.
- W2998173885 cites W2120462386 @default.
- W2998173885 cites W2120673934 @default.
- W2998173885 cites W2127185770 @default.
- W2998173885 cites W2130163382 @default.
- W2998173885 cites W2149639441 @default.
- W2998173885 cites W2156353875 @default.
- W2998173885 cites W2172181565 @default.
- W2998173885 cites W2196970594 @default.
- W2998173885 cites W2198093519 @default.
- W2998173885 cites W2464221347 @default.
- W2998173885 cites W2527905628 @default.
- W2998173885 cites W2560367415 @default.
- W2998173885 cites W2567564314 @default.
- W2998173885 cites W2572174216 @default.
- W2998173885 cites W2577696913 @default.
- W2998173885 cites W2590837684 @default.
- W2998173885 cites W2606602030 @default.
- W2998173885 cites W2613962944 @default.
- W2998173885 cites W2637316398 @default.
- W2998173885 cites W2737542013 @default.
- W2998173885 cites W2753065806 @default.
- W2998173885 cites W2766276773 @default.
- W2998173885 cites W2767140416 @default.
- W2998173885 cites W2769504310 @default.
- W2998173885 cites W2777555897 @default.
- W2998173885 cites W2781525129 @default.
- W2998173885 cites W2789776333 @default.
- W2998173885 cites W2791290180 @default.
- W2998173885 cites W2796582438 @default.
- W2998173885 cites W2806107339 @default.
- W2998173885 cites W2883638671 @default.
- W2998173885 cites W2885552267 @default.
- W2998173885 cites W2888880602 @default.
- W2998173885 cites W2892640821 @default.
- W2998173885 cites W2894976549 @default.
- W2998173885 cites W2902078827 @default.
- W2998173885 cites W2904843992 @default.
- W2998173885 cites W2905049840 @default.
- W2998173885 cites W2906175764 @default.
- W2998173885 cites W2906812140 @default.
- W2998173885 cites W2912553233 @default.
- W2998173885 cites W2917722773 @default.
- W2998173885 cites W2924849767 @default.
- W2998173885 cites W2936706033 @default.
- W2998173885 cites W2940759533 @default.
- W2998173885 cites W2945590213 @default.
- W2998173885 cites W2947786707 @default.
- W2998173885 cites W2954747398 @default.
- W2998173885 cites W4240394569 @default.
- W2998173885 doi "https://doi.org/10.3390/cancers12010067" @default.
- W2998173885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7016680" @default.
- W2998173885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31881699" @default.
- W2998173885 hasPublicationYear "2019" @default.
- W2998173885 type Work @default.
- W2998173885 sameAs 2998173885 @default.
- W2998173885 citedByCount "35" @default.
- W2998173885 countsByYear W29981738852020 @default.
- W2998173885 countsByYear W29981738852021 @default.
- W2998173885 countsByYear W29981738852022 @default.
- W2998173885 countsByYear W29981738852023 @default.
- W2998173885 crossrefType "journal-article" @default.
- W2998173885 hasAuthorship W2998173885A5004176474 @default.
- W2998173885 hasAuthorship W2998173885A5005810267 @default.
- W2998173885 hasAuthorship W2998173885A5008445367 @default.
- W2998173885 hasAuthorship W2998173885A5009935310 @default.
- W2998173885 hasAuthorship W2998173885A5011289747 @default.
- W2998173885 hasAuthorship W2998173885A5018257698 @default.